Goodwin’s Paris Private Equity team advised Demea Agro, formerly Cerea Partners, a French asset management firm specializing in the agri-food sector, on the sale of Polaris to Motion Equity Partners.
As part of the transaction, Demea Agro will reinvest alongside Polaris’ management team and longstanding co-investors Seventure and Picama.
The transaction will support Polaris’ continued growth by accelerating its international expansion, particularly in the United States, advancing investment in innovation and enabling the company to pursue further strategic acquisitions.
Founded in Brittany in 1994, Polaris is a leading biotechnology company specializing in the development and production of omega-3-rich oils derived from marine sources and microalgae. Drawing on its expertise in lipid chemistry and proprietary technologies, Polaris supplies high-value nutritional ingredients to customers worldwide, particularly in the nutraceutical and infant nutrition sectors.
The Goodwin team included Thomas Maitrejean, Thomas Dupont-Sentilles, and Ronan Pflieger on corporate matters, as well as Marie-Laure Bruneel on tax matters.